S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Bear Market Funds to Watch This Year
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities

REGENXBIO (RGNX) Earnings Date, Estimates & Call Transcripts

$16.11
-0.92 (-5.40%)
(As of 04/18/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 27)
-$1.43 Missed By -$0.16
Consensus EPS
(Feb. 27)
-$1.27
Skip Charts & View Estimated and Actual Earnings Data

RGNX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGNX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

REGENXBIO Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($1.50)($1.11)($1.29)
Q2 20243($1.40)($1.11)($1.24)
Q3 20243($1.39)($1.11)($1.23)
Q4 20243($1.39)($1.10)($1.22)
FY 202412($5.68)($4.43)($4.97)
Q1 20251($1.35)($1.35)($1.35)
Q2 20251($1.29)($1.29)($1.29)
Q3 20251($1.28)($1.28)($1.28)
Q4 20251($1.23)($1.23)($1.23)
FY 20254($5.15)($5.15)($5.15)

RGNX Earnings Date and Information

REGENXBIO last posted its quarterly earnings data on February 27th, 2024. The biotechnology company reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($1.27) by $0.16. The business earned $22.30 million during the quarter, compared to analyst estimates of $34.01 million. Its quarterly revenue was down 28.8% compared to the same quarter last year. REGENXBIO has generated ($6.03) earnings per share over the last year (($6.03) diluted earnings per share). Earnings for REGENXBIO are expected to grow in the coming year, from ($3.98) to ($3.28) per share. REGENXBIO has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

REGENXBIO Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
2/27/2024Q4 2023($1.27)($1.43)($0.16)($1.43)$34.01 million$22.30 million    
11/8/2023Q3 2023($1.44)($1.41)+$0.03($1.41)$26.14 million$28.90 million    
8/2/2023Q2 2023($1.26)($1.66)($0.40)($1.66)$34.50 million$19.98 million    
5/3/2023Q1 2023($1.52)($1.53)($0.01)($1.53)$31.29 million$19.10 million    
2/28/2023Q4 2022($1.48)($1.38)+$0.10($1.38)$37.45 million$31.35 million    
11/3/2022Q3 2022($1.55)($1.75)($0.20)($1.75)$29.77 million$26.51 million    
8/3/2022Q2 2022($1.44)($1.58)($0.14)($1.58)$26.00 million$32.65 million
5/4/2022Q1 2022($1.29)($1.62)($0.33)($1.45)$28.13 million$22.22 million
3/1/2022Q4 2021$4.28$6.67+$2.39$6.67$255.76 million$398.66 million    
11/2/2021Q3 2021($0.87)($1.37)($0.50)($1.37)$49.35 million$30.77 million    
8/9/2021Q2 2021($1.08)($1.36)($0.28)($1.36)$21.17 million$22.04 million    
5/5/2021Q1 2021($1.13)($1.20)($0.07)($1.20)$27.97 million$18.88 million  

REGENXBIO Earnings - Frequently Asked Questions

When is REGENXBIO's earnings date?

REGENXBIO has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on RGNX's earnings history.

Did REGENXBIO beat their earnings estimates last quarter?

In the previous quarter, REGENXBIO (NASDAQ:RGNX) missed the analysts' consensus estimate of ($1.27) by $0.16 with a reported earnings per share (EPS) of ($1.43). Learn more on analysts' earnings estimate vs. RGNX's actual earnings.

How can I listen to REGENXBIO's earnings conference call?

The conference call for REGENXBIO's latest earnings report can be listened to online. Listen to Conference Call

How can I read REGENXBIO's conference call transcript?

The conference call transcript for REGENXBIO's latest earnings report can be read online. Read Transcript

How much revenue does REGENXBIO generate each year?

REGENXBIO (NASDAQ:RGNX) has a recorded annual revenue of $90.24 million.

How much profit does REGENXBIO generate each year?

REGENXBIO (NASDAQ:RGNX) has a recorded net income of -$263.49 million. RGNX has generated -$6.03 earnings per share over the last four quarters.

What is REGENXBIO's EPS forecast for next year?

REGENXBIO's earnings are expected to grow from ($3.98) per share to ($3.28) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RGNX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners